Thomas Kim, MD
Cardiology · Santa Ana, CANPI 1144225301
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Abbott at 30.6% of the total. Among cardiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 653 payments — averaging $71.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$14K
- Edwards Lifesciences$13K
- Medtronic$10K
- Novartis$2K
- Boston Scientific$859
- Amgen$832
- plus $6K from 31 others
Across 1 payment — averaging $23.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$23
What the payments were for
- Consulting fees$10,92323%
- Speaking & faculty fees$2,0004%
- Grants$5401%
- Travel & lodging$12,79528%
- Food & beverage$20,17743%
- Gifts$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 95 | $14,253 |
| Edwards Lifesciences | 37 | $12,643 |
| Medtronic(2 entities) | 110 | $10,495 |
| Novartis | 133 | $1,877 |
| Boston Scientific | 13 | $859 |
| Amgen | 31 | $832 |
| Pfizer | 45 | $665 |
| Johnson & Johnson(2 entities) | 32 | $420 |
| E.r. Squibb & Sons, L.L.C. | 18 | $415 |
| Boehringer Ingelheim | 16 | $388 |
| Cvrx, Inc. | 3 | $343 |
| Actelion Pharmaceuticals US, Inc. | 18 | $333 |
| Impulse Dynamics (USA) Inc. | 9 | $324 |
| Sanofi-aventis U.S. LLC | 11 | $317 |
| Abiomed | 4 | $316 |
| Cathworks, Inc. | 2 | $283 |
| Chiesi USA, Inc. | 10 | $248 |
| AstraZeneca | 15 | $240 |
| Scpharmaceuticals Inc. | 10 | $214 |
| Cardiovascular Systems Inc. | 9 | $176 |
| Bridgebio Pharma, Inc. | 2 | $133 |
| Shockwave Medical, Inc | 1 | $126 |
| Alnylam Pharmaceuticals Inc. | 4 | $94 |
| Cardiva Medical, Inc. | 3 | $81 |
| Kestra Medical Technology Services, Inc. | 3 | $71 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $70 |
| Astellas Pharma US Inc | 3 | $57 |
| Irhythm Technologies, Inc. | 2 | $48 |
| Novo Nordisk | 1 | $33 |
| Merck | 1 | $30 |
| Gilead | 2 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $21 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Atricure, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$7,859
- Micra$3,019
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$2,269
- MitraClip$2,124
- CARDIOMEMS$2,084
- Cardiac Mapping System$1,877
- ASSURITY$1,498
- AVEIR$895
- MitraClip System$867
- PASCAL$747
- ACCENT$629
- SAPIEN 3 Ultra RESILIA$622
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$499
- OPTIMIZER$352
- AZURE XT DR MRI SURESCAN$333
- Barostim Neo System$304
- FFRangio System$283
- Mitra Clip system$270
- LINQ II$268
- Tricuspid Valve Repair System$263
How this compares
$46,509 in reported general payments places this provider in the 95th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 542 | $506,857 |
| EntrestoSacubitril/Valsartan | 231 | $202,493 |
| XareltoRivaroxaban | 77 | $70,049 |
| Repatha SureclickEvolocumab | 35 | $27,564 |
| FarxigaDapagliflozin Propanediol | 22 | $21,773 |
| JardianceEmpagliflozin | 24 | $20,954 |
| Valsartan | 275 | $6,453 |
| Carvedilol | 481 | $4,500 |
| Metoprolol Succinate | 241 | $3,382 |
| Atorvastatin Calcium | 274 | $3,004 |
| Rosuvastatin Calcium | 187 | $2,796 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 74 | $2,688 |
| Nisoldipine | 11 | $2,607 |
| Losartan Potassium | 347 | $2,587 |
| ClopidogrelClopidogrel Bisulfate | 207 | $2,013 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $665 | $506,857542 claims |
| NovartisEntresto | $1,877 | $202,493231 claims |
| Johnson & JohnsonXarelto | $420 | $70,04977 claims |
| AstraZenecaFarxiga | $240 | $21,77322 claims |
| Boehringer IngelheimJardiance | $388 | $20,95424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 156 cardiology providers in California.
Other cardiology in Santa Ana
- Anil ShahSanta Ana$49K
- Amer ZarkaSanta Ana$6K
- Stephen CohenSanta Ana$6K
- Mahmoud Eslami-FarsaniSanta Ana$5K
- Bahram EslamiSanta Ana$4K
- Paul MeltzerSanta Ana$2K
- Norman LeporBeverly Hills$1.9M
- Sanjay KaulLos Angeles$1.1M
- Ramtin AgahMountain View$361K
- Jamshid MaddahiLos Angeles$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.